Literature DB >> 18467357

Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.

J P Kaski1, P Syrris, M Burch, M-T Tomé-Esteban, M Fenton, M Christiansen, P S Andersen, N Sebire, M Ashworth, J E Deanfield, W J McKenna, P M Elliott.   

Abstract

BACKGROUND: Restrictive cardiomyopathy (RCM) is rare in childhood, but has a grave prognosis. The cause of disease in most cases is unknown.
OBJECTIVE: To determine the prevalence of sarcomere protein gene mutations in children with idiopathic RCM.
METHODS: Twelve patients (9 female, mean age 5.1 years) with idiopathic RCM referred between 1991 and August 2006 underwent detailed clinical and genetic evaluation. Nine had received cardiac transplants at the time of the study. The entire coding sequences of the genes encoding eight cardiac sarcomere proteins and desmin were screened for mutations. Familial evaluation was performed on first-degree relatives.
RESULTS: Four patients (33%) had a family history of cardiomyopathy: RCM (n = 2); dilated cardiomyopathy (n = 1) and left ventricular non-compaction (n = 1). Sarcomere protein gene mutations were identified in four patients (33%): 2 in the cardiac troponin I gene (TNNI3) and 1 each in the troponin T (TNNT2) and alpha-cardiac actin (ACTC) genes. Two were de novo mutations and 3 were new mutations. All mutations occurred in functionally important and conserved regions of the genes.
CONCLUSIONS: Sarcomere protein gene mutations are an important cause of idiopathic RCM in childhood. We describe the first mutation in ACTC in familial RCM. The identification of RCM in a child should prompt consideration of sarcomere protein disease as a possible cause and warrants clinical evaluation of the family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467357     DOI: 10.1136/hrt.2007.134684

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  59 in total

Review 1.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

2.  Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy.

Authors:  E Otten; R H Lekanne Dit Deprez; M M Weiss; M van Slegtenhorst; M Joosten; J J van der Smagt; N de Jonge; W S Kerstjens-Frederikse; M T R Roofthooft; A H M M Balk; M P van den Berg; J S Ruiter; J P van Tintelen
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

Review 3.  Genetics of inherited cardiomyopathy.

Authors:  Daniel Jacoby; William J McKenna
Journal:  Eur Heart J       Date:  2011-08-02       Impact factor: 29.983

4.  A Restrictive Cardiomyopathy Mutation in an Invariant Proline at the Myosin Head/Rod Junction Enhances Head Flexibility and Function, Yielding Muscle Defects in Drosophila.

Authors:  Madhulika Achal; Adriana S Trujillo; Girish C Melkani; Gerrie P Farman; Karen Ocorr; Meera C Viswanathan; Gaurav Kaushik; Christopher S Newhard; Bernadette M Glasheen; Anju Melkani; Jennifer A Suggs; Jeffrey R Moore; Douglas M Swank; Rolf Bodmer; Anthony Cammarato; Sanford I Bernstein
Journal:  J Mol Biol       Date:  2016-04-20       Impact factor: 5.469

5.  Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto
Journal:  Biochim Biophys Acta       Date:  2014-11-01

6.  Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy.

Authors:  Nathan R Tucker; Micheal A McLellan; Dongjian Hu; Jiangchuan Ye; Victoria A Parsons; Robert W Mills; Sebastian Clauss; Elena Dolmatova; Marisa A Shea; David J Milan; Nandita S Scott; Mark Lindsay; Steven A Lubitz; Ibrahim J Domian; James R Stone; Honghuang Lin; Patrick T Ellinor
Journal:  Circ Cardiovasc Genet       Date:  2017-12

7.  Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy.

Authors:  Takeharu Hayashi; Kousuke Tanimoto; Kayoko Hirayama-Yamada; Etsuko Tsuda; Mamoru Ayusawa; Shinichi Nunoda; Akira Hosaki; Akinori Kimura
Journal:  J Hum Genet       Date:  2018-06-15       Impact factor: 3.172

8.  Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss?

Authors:  Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2009-07-21       Impact factor: 24.094

Review 9.  Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction.

Authors:  Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2009-01-29       Impact factor: 1.655

Review 10.  Cardiac troponin mutations and restrictive cardiomyopathy.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; David Dweck; James D Potter
Journal:  J Biomed Biotechnol       Date:  2010-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.